Literature DB >> 3923811

Tocainide associated agranulocytosis.

K Volosin, R M Greenberg, A J Greenspon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3923811     DOI： 10.1016/0002-8703(85)90373-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  5 in total

Review 1.  Adverse effects of class I antiarrhythmic drugs.

Authors:  J Caron; C Libersa
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

2.  Tocainide and myotonic dystrophy.

Authors:  R Harries-Jones
Journal:  J Neurol       Date:  1986-06       Impact factor: 4.849

Review 3.  Drug infusions for the diagnosis and treatment of chronic pain.

Authors:  David A O'Gorman; Srinivasa N Raja
Journal:  Curr Pain Headache Rep       Date:  2002-12

Review 4.  Assessment of the risk-benefit ratio for antiarrhythmic drug use.

Authors:  R W Campbell
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

Review 5.  The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment.

Authors:  E Matthews; D Fialho; S V Tan; S L Venance; S C Cannon; D Sternberg; B Fontaine; A A Amato; R J Barohn; R C Griggs; M G Hanna
Journal:  Brain       Date:  2009-11-16       Impact factor: 13.501
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.